A significant recall of antidepressants was prompted by a patient discovering the wrong medication in their pack. More than 80,000 packs of Sertraline have been recalled due to incorrect packaging.
On April 29, 2026, Amarox Limited initiated the recall as a precautionary measure. The issue arose when a patient found Citalopram tablets inside a pack of Sertraline.
Both Sertraline and Citalopram are SSRIs used to treat depression and anxiety. The error occurred during the secondary packaging of the blister strips into cartons.
As of midday, patients who mistakenly took Citalopram should seek medical advice immediately. Dr. Alison Cave emphasized the risks involved.
Key facts:
- The affected batch number is V2500425.
- The total batch size is 81,872 packs.
- Patients may experience heightened serotonergic side effects from taking Citalopram instead of Sertraline.
Dr. Cave noted that these side effects can include nausea, headache, sleep changes, and mild anxiety. Officials have not confirmed how many patients might be affected by this medication error.
This incident raises concerns about patient safety in mental health treatment. In 2019 alone, over 16.7 million prescriptions of Sertraline were issued in England.
As the situation develops, Amarox Limited is expected to provide further updates regarding the recall and its implications for patients.